Bovine brucellosis
1. The programmes for the eradication of bovine brucellosis submitted by Ireland, Spain, Italy, Cyprus, Portugal and the United Kingdom are hereby approved for the period from 1 January 2008 to 31 December 2008.
2. The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of carrying out laboratory tests, the compensation to owners for the value of their animals slaughtered subject to those programmes and the purchase of vaccine doses, and shall not exceed:
(a)
EUR 1 200 000 for Ireland;
(b)
EUR 4 400 000 for Spain;
(c)
EUR 2 100 000 for Italy;
(d)
EUR 153 000 for Cyprus;
(e)
EUR 1 900 000 for Portugal;
(f)
EUR 1 200 000 for the United Kingdom.
3. The maximum amounts of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall not exceed:
(a)
for a rose bengal test
EUR 0,2 per test;
(b)
for a SAT test
EUR 0,2 per test;
(c)
for a complement fixation test
EUR 0,4 per test;
(d)
for an ELISA test
EUR 1 per test.
Bovine tuberculosis
1. The programmes for the eradication of bovine tuberculosis submitted by Estonia, Spain, Italy, Poland and Portugal are hereby approved for the period from 1 January 2008 to 31 December 2008.
2. The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the costs of carrying out tuberculin tests, laboratory tests and the compensation to owners for the value of their animals slaughtered subject to those programmes, and shall not exceed:
(a)
EUR 24 000 for Estonia;
(b)
EUR 6 100 000 for Spain;
(c)
EUR 2 700 000 for Italy;
(d)
EUR 1 100 000 for Poland;
(e)
EUR 347 000 for Portugal.
3. The maximum amounts of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall not exceed:
(a)
for a tuberculin test
EUR 1 per test;
(b)
for a gamma-interferon test
EUR 5 per test.
Ovine and caprine brucellosis
1. The programmes for the eradication of ovine and caprine brucellosis submitted by Spain, Italy, Cyprus and Portugal are hereby approved for the period from 1 January 2008 to 31 December 2008.
2. The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the purchase of vaccines, the cost of carrying out laboratory tests and the compensation to owners for the value of their animals slaughtered subject to those programmes, and shall not exceed:
(a)
EUR 5 600 000 for Spain;
(b)
EUR 2 800 000 for Italy;
(c)
EUR 93 000 for Cyprus;
(d)
EUR 1 100 000 for Portugal.
3. The maximum amounts of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall not exceed:
(a)
for a rose bengal test
EUR 0,2 per test;
(b)
for a complement fixation test
EUR 0,4 per test.
Bluetongue in endemic or high risk areas
1. The programmes for the eradication and monitoring of bluetongue submitted by Belgium, Bulgaria, Germany, Greece, Spain, France, Italy, Luxembourg the Netherlands, Austria, Portugal, Romania and Slovenia are hereby approved for the period from 1 January 2008 to 31 December 2008.
2. The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of carrying out the laboratory tests for virological, serological and entomological surveillance and the purchase of traps and vaccines, and shall not exceed:
(a)
EUR 377 000 for Belgium;
(b)
EUR 5 400 for Bulgaria;
(c)
EUR 3 100 000 for Germany;
(d)
EUR 100 000 for Greece;
(e)
EUR 4 100 000 for Spain;
(f)
EUR 351 000 for France;
(g)
EUR 1 300 000 for Italy;
(h)
EUR 70 000 for Luxemburg;
(i)
EUR 527 000 for the Netherlands;
(j)
EUR 245 000 for Austria;
(k)
EUR 1 004 000 for Portugal;
(l)
EUR 43 000 for Romania;
(m)
EUR 61 000 for Slovenia.
3. The maximum amounts of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall not exceed for an ELISA test EUR 2,5 per test.
Salmonellosis (zoonotic salmonella) in breeding flocks of Gallus gallus
1. The programmes for the control of certain zoonotic salmonella in breeding flocks of Gallus gallus submitted by Belgium, Bulgaria, the Czech Republic, Denmark, Germany, Ireland, Greece, Spain, France, Italy, Cyprus, Latvia, Hungary, the Netherlands, Austria, Poland, Portugal, Romania and Slovakia are hereby approved for the period from 1 January 2008 to 31 December 2008.
2. The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of carrying out bacteriological and serotyping tests in the framework of official sampling, the compensation to owners for the value of the birds culled, the destruction of eggs and the purchase of vaccine doses and shall not exceed:
(a)
EUR 550 000 for Belgium;
(b)
EUR 10 000 for Bulgaria;
(c)
EUR 200 000 for the Czech Republic;
(d)
EUR 75 000 for Denmark;
(e)
EUR 600 000 for Germany;
(f)
EUR 120 000 for Ireland;
(g)
EUR 150 000 for Greece;
(h)
EUR 800 000 for Spain;
(i)
EUR 500 000 for France;
(j)
EUR 470 000 for Italy;
(k)
EUR 45 000 for Cyprus;
(l)
EUR 60 000 for Latvia;
(m)
EUR 400 000 for Hungary;
(n)
EUR 1 300 000 for the Netherlands;
(o)
EUR 50 000 for Austria;
(p)
EUR 2 000 000 for Poland;
(q)
EUR 600 000 for Portugal;
(r)
EUR 400 000 for Romania;
(s)
EUR 275 000 for Slovakia.
3. The maximum amounts of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall not exceed:
(a)
for a bacteriological test (cultivation)
EUR 5,0 per test;
(b)
for the purchase of one vaccine dose
EUR 0,05 per dose;
(c)
for serotyping of relevant isolates of Salmonella spp .
EUR 20,0 per test.
Salmonellosis (zoonotic salmonella) in laying flocks of Gallus gallus
1. The programmes for the control of certain zoonotic salmonella in laying flocks of Gallus gallus submitted by Belgium, Bulgaria, the Czech Republic, Germany, Estonia, Greece, Spain, France, Italy, Cyprus, Latvia, Luxembourg, Hungary, the Netherlands, Austria, Poland, Portugal, Romania, Slovakia and United Kingdom are hereby approved for the period from 1 January 2008 to 31 December 2008.
2. The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of carrying out bacteriological and serotyping tests in the framework of official sampling, the compensation to owners for the value of the birds culled, the destruction of eggs and the purchase of vaccine doses, and shall not exceed:
(a)
EUR 750 000 for Belgium;
(b)
EUR 20 000 for Bulgaria;
(c)
EUR 1 000 000 for the Czech Republic;
(d)
EUR 2 000 000 for Germany;
(e)
EUR 20 000 for Estonia;
(f)
EUR 500 000 for Greece;
(g)
EUR 3 500 000 for Spain;
(h)
EUR 2 500 000 for France;
(i)
EUR 1 000 000 for Italy;
(j)
EUR 80 000 for Cyprus;
(k)
EUR 300 000 for Latvia;
(l)
EUR 10 000 for Luxembourg;
(m)
EUR 2 000 000 for Hungary;
(n)
EUR 2 000 000 for the Netherlands;
(o)
EUR 1 000 000 for Austria;
(p)
EUR 2 000 000 for Poland;
(q)
EUR 1 000 000 for Portugal;
(r)
EUR 500 000 for Romania;
(s)
EUR 1 000 000 for Slovakia;
(t)
EUR 80 000 for United Kingdom.
3. The maximum amounts of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall not exceed:
(a)
for a bacteriological test (cultivation)
EUR 5,0 per test;
(b)
for the purchase of one vaccine dose
EUR 0,05 per dose;
(c)
for serotyping of relevant isolates of Salmonella spp .
EUR 20,0 per test.
Classical swine fever and African swine fever
1. The programmes for the control and monitoring of:
(a)
Classical swine fever submitted by Bulgaria, Germany, France, Luxembourg, Romania, Slovenia and Slovakia are hereby approved for the period from 1 January 2008 to 31 December 2008.
(b)
Classical swine fever and African swine fever submitted by Italy are hereby approved for the period from 1 January 2008 to 31 December 2008.
2. The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of carrying out virological and serological tests of domestic pigs and wild boars and for the programmes submitted by Bulgaria, Germany, France, Romania and Slovakia also at the rate of 50 % of the costs to be incurred for the purchase and distribution of vaccines plus baits for the vaccination of wild boars, and shall not exceed:
(a)
EUR 400 000 for Bulgaria;
(b)
EUR 1 000 000 for Germany;
(c)
EUR 650 000 for France;
(d)
EUR 100 000 for Italy;
(e)
EUR 15 000 for Luxembourg;
(f)
EUR 2 500 000 for Romania;
(g)
EUR 40 000 for Slovenia;
(h)
EUR 525 000 for Slovakia.
3. The maximum amounts of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall not exceed for an ELISA test EUR 2,5 per test.
Swine vesicular disease
1. The programme for the eradication of swine vesicular disease submitted by Italy is hereby approved for the period from 1 January 2008 to 31 December 2008.
2. The financial contribution by the Community shall be at the rate of 50 % of the cost of laboratory tests and shall not exceed EUR 300 000.
Avian influenza in poultry and wild birds
1. The survey programmes for avian influenza in poultry and wild birds submitted by Belgium, Bulgaria, the Czech Republic, Denmark, Germany, Estonia, Ireland, Greece, Spain, France, Italy, Cyprus, Latvia, Lithuania, Luxembourg, Hungary, the Netherlands, Austria, Poland, Portugal, Romania, Slovenia, Slovakia, Finland, Sweden and the United Kingdom are hereby approved for the period from 1 January 2008 to 31 December 2008.
2. The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State for the costs of carrying out laboratory tests and a lump sum for sampling of wild birds, and shall not exceed:
(a)
EUR 127 000 for Belgium;
(b)
EUR 76 000 for Bulgaria;
(c)
EUR 65 000 for the Czech Republic;
(d)
EUR 202 000 for Denmark;
(e)
EUR 580 000 for Germany;
(f)
EUR 8 000 for Estonia;
(g)
EUR 58 000 for Ireland;
(h)
EUR 72 000 for Greece;
(i)
EUR 306 000 for Spain;
(j)
EUR 155 000 for France;
(k)
EUR 380 000 for Italy;
(l)
EUR 15 000 for Cyprus;
(m)
EUR 33 000 for Latvia;
(n)
EUR 43 000 for Lithuania;
(o)
EUR 12 000 for Luxembourg;
(p)
EUR 184 000 for Hungary;
(q)
EUR 444 000 for the Netherlands;
(r)
EUR 55 000 for Austria;
(s)
EUR 81 000 for Poland;
(t)
EUR 165 000 for Portugal;
(u)
EUR 465 000 for Romania;
(v)
EUR 43 000 for Slovenia;
(w)
EUR 50 000 for Slovakia;
(x)
EUR 35 000 for Finland;
(y)
EUR 290 000 for Sweden;
(z)
EUR 400 000 for the United Kingdom.
3. The maximum amounts of the costs to be reimbursed to the Member States for the tests covered by the programmes shall not exceed:
(a)
ELISA test:
EUR 1 per test;
(b)
agar gel immune diffusion test:
EUR 1,2 per test;
(c)
HI test for H5/H7:
EUR 12 per test;
(d)
virus isolation test:
EUR 30 per test;
(e)
PCR test:
EUR 15 per test;
(f)
sampling wild birds
EUR 20 per bird.
Transmissible spongiform encephalopathies (TSE)
1. The programmes for the monitoring of transmissible spongiform encephalopathies (TSEs) submitted by Belgium, Bulgaria, the Czech Republic, Denmark, Germany, Estonia, Ireland, Greece, Spain, France, Italy, Cyprus, Latvia, Lithuania, Luxembourg, Hungary, Malta, the Netherlands, Austria, Poland, Portugal, Romania, Slovenia, Slovakia, Finland, Sweden, and the United Kingdom are hereby approved for the period from 1 January 2008 to 31 December 2008.
2. The financial contribution by the Community shall be at the rate of 100 % of the costs to be incurred by each Member State referred to in paragraph 1 for the implementation of those programmes, and shall not exceed:
(a)
EUR 1 950 000 for Belgium;
(b)
EUR 850 000 for Bulgaria;
(c)
EUR 950 000 for the Czech Republic;
(d)
EUR 1 600 000 for Denmark;
(e)
EUR 9 500 000 for Germany;
(f)
EUR 250 000 for Estonia;
(g)
EUR 5 000 000 for Ireland;
(h)
EUR 950 000 for Greece;
(i)
EUR 4 700 000 for Spain;
(j)
EUR 14 750 000 for France;
(k)
EUR 3 050 000 for Italy;
(l)
EUR 250 000 for Cyprus;
(m)
EUR 300 000 for Latvia;
(n)
EUR 550 000 for Lithuania;
(o)
EUR 150 000 for Luxembourg;
(p)
EUR 700 000 for Hungary;
(q)
EUR 37 000 for Malta;
(r)
EUR 3 150 000 for the Netherlands;
(s)
EUR 1 250 000 for Austria;
(t)
EUR 3 250 000 for Poland;
(u)
EUR 1 250 000 for Portugal;
(v)
EUR 7 500 for Romania;
(w)
EUR 200 000 for Slovenia;
(x)
EUR 750 000 for Slovakia;
(y)
EUR 650 000 for Finland;
(z)
EUR 1 150 000 for Sweden;
(za)
EUR 5 300 000 for the United Kingdom.
3. The financial contribution by the Community of the programmes referred to in paragraph 1 shall be for the tests performed and the maximum amount shall not exceed:
(a)
EUR 5 per test, for tests carried out in bovine animals referred to in Annex III to Regulation (EC) No 999/2001;
(b)
EUR 30 per test, for tests carried out in ovine and caprine animals referred to in Annex III to Regulation (EC) No 999/2001;
(c)
EUR 50 per test, for tests carried out in cervid animals referred to in Annex III to Regulation (EC) No 999/2001;
(d)
EUR 175 per test, for primary molecular discriminatory tests carried out as referred to in point 3.2(c)(i) of Chapter C of Annex X to Regulation (EC) No 999/2001.
Bovine spongiform encephalopathy (BSE)
1. The programmes for the eradication of bovine spongiform encephalopathy submitted by Belgium, Bulgaria, the Czech Republic, Denmark, Germany, Estonia, Ireland, Greece, Spain, France, Italy, Luxembourg, the Netherlands, Austria, Poland, Portugal, Slovenia, Slovakia, Finland and the United Kingdom are hereby approved for the period from 1 January 2008 to 31 December 2008.
2. The financial contribution by the Community of the programmes referred to in paragraph 1 shall be at the rate of 50 % of the cost incurred by each Member State for the compensation to owners for the value of their animals culled and destroyed in accordance with their eradication programme, up to a maximum of EUR 500 per animal, and shall not exceed:
(a)
EUR 50 000 for Belgium;
(b)
EUR 50 000 for Bulgaria;
(c)
EUR 150 000 for the Czech Republic;
(d)
EUR 50 000 for Denmark;
(e)
EUR 145 000 for Germany;
(f)
EUR 50 000 for Estonia;
(g)
EUR 430 000 for Ireland;
(h)
EUR 50 000 for Greece;
(i)
EUR 500 000 for Spain;
(j)
EUR 100 000 for France;
(k)
EUR 150 000 for Italy;
(l)
EUR 50 000 for Luxembourg;
(m)
EUR 50 000 for the Netherlands;
(n)
EUR 50 000 for Austria;
(o)
EUR 100 000 for Poland;
(p)
EUR 232 000 for Portugal;
(q)
EUR 10 000 for Slovenia;
(r)
EUR 125 000 for Slovakia;
(s)
EUR 25 000 for Finland;
(t)
EUR 176 000 for the United Kingdom.
Scrapie
1. The programmes for the eradication of scrapie submitted by Belgium, Bulgaria, the Czech Republic, Denmark, Germany, Estonia, Ireland, Greece, Spain, France, Italy, Cyprus, Latvia, Lithuania, Luxembourg, Hungary, the Netherlands, Austria, Portugal, Romania, Slovenia, Slovakia, Finland, and the United Kingdom are hereby approved for the period from 1 January 2008 to 31 December 2008.
2. The financial contribution by the Community of the programmes referred to in paragraph 1 shall be at the rate of 50 % of the cost incurred by the concerned Member States for compensation to owners for the value of their animals culled and destroyed in accordance with their eradication programme, up to a maximum of EUR 100 per animal and at a rate of 50 % of the cost of the analysis of samples for genotyping, up to a maximum of EUR 10 per genotyping test, and shall not exceed:
(a)
EUR 66 000 for Belgium;
(b)
EUR 26 000 for Bulgaria;
(c)
EUR 88 000 for the Czech Republic;
(d)
EUR 204 000 for Denmark;
(e)
EUR 1 000 000 for Germany;
(f)
EUR 12 100 for Estonia;
(g)
EUR 550 000 for Ireland;
(h)
EUR 700 000 for Greece;
(i)
EUR 3 800 000 for Spain;
(j)
EUR 3 000 000 for France;
(k)
EUR 1 500 000 for Italy;
(l)
EUR 1 100 000 for Cyprus;
(m)
EUR 1 100 for Latvia;
(n)
EUR 3 000 for Lithuania;
(o)
EUR 27 000 for Luxembourg;
(p)
EUR 343 000 for Hungary;
(q)
EUR 258 000 for the Netherlands;
(r)
EUR 26 000 for Austria;
(s)
EUR 35 000 for Portugal;
(t)
EUR 881 000 for Romania;
(u)
EUR 61 000 for Slovenia;
(v)
EUR 302 000 for Slovakia;
(w)
EUR 201 000 for Finland;
(x)
EUR 4 000 000 for the United Kingdom.
Rabies
1. The programmes for the eradication of rabies submitted by Bulgaria, Lithuania, Hungary, Austria, Poland, Romania and Slovakia are hereby approved for the period from 1 January 2008 to 31 December 2008.
2. The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of carrying out laboratory tests and for the purchase and distribution of vaccine plus baits for the programmes, and shall not exceed:
(a)
EUR 700 000 for Bulgaria;
(b)
EUR 700 000 for Lithuania;
(c)
EUR 1 500 000 for Hungary;
(d)
EUR 290 000 for Austria;
(e)
EUR 3 900 000 for Poland;
(f)
EUR 2 500 000 for Romania;
(g)
EUR 575 000 for Slovakia.
3. The maximum amounts of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall not exceed:
(a)
for an ELISA test
EUR 8 per test;
(b)
for a test to detect tetracycline in bone
EUR 8 per test.
Enzootic bovine leucosis
1. The programme for the eradication of enzootic bovine leucosis submitted by Estonia, Lithuania and Poland for the period from 1 January to 31 December 2008 is hereby approved.
2. The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of carrying out laboratory tests and compensation to owners for the value of their animals slaughtered subject to those programmes, and shall not exceed EUR:
(a)
EUR 15 000 for Estonia;
(b)
EUR 200 000 for Lithuania;
(c)
EUR 800 000 for Poland.
3. The maximum amounts of the costs to be reimbursed to the Member States for the programme referred to in paragraph 1 shall not exceed:
(a)
for an ELISA test
EUR 0,5 per test;
(b)
for an agar gel immune diffusion test
EUR 0,5 per test.
Aujeszky’s disease
1. The programmes for the eradication of Aujeszky’s disease submitted by Spain, Hungary and Poland is hereby approved for the period from 1 January 2008 to 31 December 2008.
2. The financial contribution by the Community of the programmes referred to in paragraph 1 shall be at the rate of 50 % of the costs to be incurred by the concerned Member State for the cost of laboratory tests, and shall not exceed:
(a)
EUR 450 000 for Spain;
(b)
EUR 60 000 for Hungary;
(c)
EUR 5 000 000 for Poland.
3. The maximum amount of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall not exceed for an ELISA test EUR 1 per test.
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.
